✦ LIBER ✦

A long-term, open-label extension study evaluating the safety of extended-release memantine (28 mg) in patients with moderate to severe Alzheimer's disease

✍ Scribed by Perhach, James; Graham, Stephen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.5.a.006 Long-term safety and tolerabil

✍ S. Bakchine; M. Rainer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Open label, multicenter, 28-week extensi

✍ Brian R. Ott; Lesley M. Blake; Ethel Kagan; Malca Resnick; for the Memantine MEM 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 142 KB

P.4.006 Long-term efficacy and safety be

✍ H.-J. Moebius; B. Reisberg; F. Schmitt; R. Doody 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 274 KB

Response across multiple outcome measure

✍ Graham, Stephen; Hendrix, Suzanne; Miller, Michael; Pejovic, Vojislav; Tocco, Mi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Effects of extended-release memantine (2

✍ Tocco, Michael; Hendrix, Suzanne; Miller, Michael; Pejovic, Vojislav; Graham, St 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Effects of extended-release memantine (2

✍ Tocco, Michael; Hendrix, Suzanne; Miller, Michael; Pejovic, Vojislav; Graham, St 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 79 KB